Does Aetna Cover ADHD Treatment in Mississippi? A 2026 Guide

Last updated: July 10, 2026

If you have Aetna health insurance in Mississippi and are looking into ADHD treatment, understanding your pharmacy and behavioral health benefits before booking an appointment can save you significant time and money. Aetna operates in Mississippi through several commercial plan types, and its pharmacy benefits are administered through CVS/Caremark — one of the country’s largest pharmacy benefit managers. Whether your plan covers a specific ADHD medication, at what cost tier, and whether prior authorization is required will depend on your specific Aetna plan and formulary year.

This guide walks through Aetna’s Mississippi plan types, the CVS/Caremark ADHD formulary, prior authorization rules, Mississippi’s mental health parity law, and how telehealth providers may fit into your coverage picture. Coverage details vary by plan — always verify your individual benefits before scheduling care.

Ready to explore ADHD treatment online? Klarity Health connects patients in Mississippi with licensed providers who can evaluate and prescribe ADHD treatment where clinically appropriate. See if ADHD treatment may be right for you →

Aetna Health Insurance Plans Available in Mississippi

Aetna offers several commercial plan types in Mississippi. The plan type you have determines your network flexibility and how referrals work for specialists, including psychiatrists and other behavioral health providers.

• Aetna Open Choice PPO: The most flexible option — members can see any licensed provider, in-network or out-of-network, without a referral. In-network visits carry lower cost-sharing. This plan type is common for employer-sponsored coverage in Mississippi.
• Aetna Elect Choice EPO: An exclusive provider organization plan where coverage is limited to in-network providers, but no PCP referral is required. Out-of-network care is generally not covered except in emergencies.
• Aetna HMO: A health maintenance organization plan requiring members to select a primary care physician (PCP). Specialist visits, including behavioral health, typically require a referral from the PCP.
• ACA Marketplace Plans: Aetna offers individual and family plans through the federal Health Insurance Marketplace for Mississippi residents. These plans follow the Affordable Care Act’s Essential Health Benefits requirements, which include mental health and substance use disorder services.

Your plan documents — available through your Aetna member portal or the Summary of Benefits and Coverage (SBC) — specify which network and formulary apply to your enrollment. Employer-sponsored plans may have customized formularies that differ from standard Aetna commercial formularies.

CVS/Caremark Formulary: Stimulant ADHD Medications

Aetna uses CVS/Caremark as its pharmacy benefit manager for most commercial plans in Mississippi. CVS/Caremark maintains a tiered drug formulary that determines how much members typically pay out-of-pocket for covered prescriptions. Stimulant medications — the most commonly prescribed first-line treatments for ADHD — are classified as Schedule II controlled substances under the federal Controlled Substances Act.

The following table reflects typical CVS/Caremark commercial formulary tier placements for stimulant ADHD medications as of 2026. Your actual cost-sharing depends on your specific plan’s deductible, copay structure, and formulary year.

Formulary tiers and cost-sharing are subject to change. Members should verify current tier placement through the Aetna member portal or CVS/Caremark pharmacy help desk before filling a prescription.

CVS/Caremark Formulary: Non-Stimulant ADHD Medications

Non-stimulant ADHD medications are an important alternative for patients who do not respond to stimulants, have contraindications, or prefer a non-controlled-substance option. Unlike stimulants, these medications are not Schedule II controlled substances, which means different prescribing rules apply (see the EPCS section below).

Prior Authorization and Step Therapy

CVS/Caremark applies prior authorization (PA) requirements to several ADHD medications under Aetna plans. Step therapy — the requirement to try a lower-tier or lower-cost medication before a higher-tier option is approved — may also apply, particularly for brand-name stimulants and newer non-stimulant agents like Qelbree.

Common PA triggers under Aetna/CVS Caremark for ADHD medications in 2026 include:

• Brand-name stimulants where a generic equivalent is available (e.g., brand Vyvanse when generic lisdexamfetamine is on formulary)
• Methylphenidate extended-release formulations above certain dose thresholds
• Qelbree (viloxazine), which typically requires documentation of trial and failure of a generic non-stimulant or stimulant
• Long-acting amphetamine formulations in some plan designs

If a PA is denied, Aetna members have the right to file an appeal. Mississippi state law and federal MHPAEA rules require that mental health PA criteria not be more stringent than those applied to comparable medical/surgical benefits. Providers may submit a PA request directly through the Aetna provider portal or via CVS/Caremark’s pharmacy help desk at 1-800-552-8159. Members can reach Aetna member services at 1-800-872-3862.

EPCS Requirements for Schedule II Stimulants in Mississippi

All stimulant ADHD medications — including amphetamine salts (Adderall), methylphenidate (Ritalin/Concerta), lisdexamfetamine (Vyvanse), and dextroamphetamine — are classified as Schedule II controlled substances under the federal Controlled Substances Act. In Mississippi, Schedule II prescriptions are subject to Electronic Prescribing for Controlled Substances (EPCS) requirements under Miss. Code Ann. § 456.44.

This means your prescribing provider must use a DEA-compliant EPCS system to transmit stimulant ADHD prescriptions electronically to your pharmacy. Paper prescriptions for Schedule II medications are generally not accepted except in limited circumstances (e.g., technological failure or pharmacy incapacity, per applicable DEA rules).

Key EPCS facts for Aetna MS members seeking ADHD stimulants:

• Telehealth providers prescribing stimulants must hold a valid DEA registration in Mississippi and use an EPCS-certified platform.
• Non-stimulant ADHD medications (atomoxetine, guanfacine ER, viloxazine, bupropion) are not Schedule II and are not subject to EPCS requirements — they may be prescribed via standard electronic prescription systems.
• CVS/Caremark-participating pharmacies in Mississippi are equipped to receive EPCS prescriptions from compliant providers.

Mississippi Mental Health Parity Law

Mississippi law requires that insured health benefit plans provide mental health and substance use disorder benefits that are no more restrictive than benefits provided for comparable medical and surgical conditions. This requirement is codified in Miss. Code Ann. § 83-9-353 et seq. and is reinforced at the federal level by the Mental Health Parity and Addiction Equity Act (MHPAEA).

Under parity rules, Aetna may not apply more stringent prior authorization criteria, visit limits, or cost-sharing to ADHD treatment than it applies to comparable physical health conditions. If you believe your plan is imposing discriminatory limits on ADHD care, you can file a complaint with the Mississippi Department of Insurance (MS DOI) at 1-800-562-2957 or contact the U.S. Department of Labor (for employer-sponsored ERISA plans).

ERISA Plans and State Law Carve-Out

Many employer-sponsored health plans in Mississippi are governed by the federal Employee Retirement Income Security Act (ERISA), which preempts most state insurance mandates — including Mississippi’s mental health parity statute. ERISA-governed plans are still subject to federal MHPAEA parity requirements, but state-level parity law enforcement may not apply. If your coverage is through an employer rather than purchased individually, check whether your plan is ERISA-governed. Your Summary Plan Description (SPD) will note if the plan is self-funded or fully insured.

Telehealth Coverage for ADHD Under Aetna Mississippi Plans

Most Aetna commercial plans in Mississippi cover telehealth behavioral health visits, including ADHD evaluations and follow-up appointments, at parity with in-person visits. Following federal and state telehealth flexibilities, many plans cover audio-visual visits for ADHD assessment and non-stimulant prescribing without a physical office visit requirement.

For stimulant ADHD medications specifically, providers must comply with DEA registration requirements for the state where the patient is located. Telehealth providers who are DEA-registered in Mississippi and use EPCS-compliant systems may be able to prescribe stimulants via video visit, depending on applicable clinical and regulatory criteria in effect at the time of your appointment.

Aetna’s telehealth network partners vary by plan type. Open Choice PPO members may have broader access to out-of-network telehealth providers. HMO and EPO members should confirm that their telehealth provider is in-network before scheduling to avoid balance billing.

Mississippi Medicaid and DOM Note

Aetna’s commercial plans described in this guide are separate from Mississippi Medicaid (administered by the Mississippi Division of Medicaid, or DOM). Aetna does not currently participate as a managed care organization in Mississippi’s Medicaid program. If you have Medicaid coverage through DOM, you will need to verify ADHD treatment coverage directly with DOM at 1-800-421-2408.

How to Verify Your Aetna ADHD Coverage Before Your Appointment

Coverage details vary by plan, year, and employer group. Before booking an ADHD evaluation or filling a new prescription, take these steps to confirm your specific benefits:

1. Log into your Aetna member portal at aetna.com or through the Aetna Health app to view your Summary of Benefits, formulary, and in-network provider directory.
2. Check your CVS/Caremark formulary by visiting the CVS/Caremark member portal or calling 1-800-552-8159. Search the specific medication your provider is likely to prescribe and confirm its tier placement and any PA requirements.
3. Call Aetna member services at 1-800-872-3862 to ask specifically about behavioral health benefits, telehealth coverage for ADHD, and whether the provider you are considering is in-network.
4. Request a benefits verification from your telehealth or in-person provider’s billing team before your first appointment — many practices will contact Aetna directly on your behalf.
5. Ask your provider about the PA process upfront. If PA is required for your prescribed medication, your provider should submit the request before you attempt to fill the prescription.

Not sure where to start? Klarity Health’s network of 2,000+ licensed providers includes clinicians who are familiar with Aetna’s ADHD coverage processes in Mississippi. Explore ADHD treatment options →

How to Access ADHD Treatment Through Klarity Health

Klarity Health connects patients across Mississippi with licensed online providers who evaluate and treat ADHD where clinically appropriate. Here is how the process typically works:

1. Complete an intake questionnaire describing your ADHD symptoms, history, and current medications.
2. Match with a licensed provider in Mississippi who specializes in ADHD evaluation and treatment.
3. Attend your video appointment — your provider will conduct a clinical evaluation and discuss whether ADHD treatment is appropriate for you.
4. Receive your prescription (if prescribed) — for non-stimulant medications, your provider will send a standard e-prescription to your preferred pharmacy. For Schedule II stimulants, your EPCS-compliant provider will transmit the prescription electronically per Mississippi law.
5. Follow up regularly — ADHD treatment typically involves ongoing check-ins to adjust medications and monitor progress.

Klarity Health is an independent platform and is not affiliated with, endorsed by, or a partner of Aetna, CVS Health, or CVS/Caremark. Coverage determinations are made solely by Aetna based on your individual plan terms.

Frequently Asked Questions

Does Aetna cover ADHD evaluations in Mississippi?

Most Aetna commercial plans in Mississippi include behavioral health benefits that may cover ADHD evaluations as an outpatient mental health service. Coverage depends on your specific plan, whether the provider is in-network, and whether any session limits apply. Verify with Aetna member services at 1-800-872-3862 before your appointment.

What ADHD medications does CVS/Caremark typically cover for Aetna members?

CVS/Caremark’s formulary for most Aetna commercial plans includes coverage for generic stimulants (amphetamine salts, methylphenidate, lisdexamfetamine generic) at Tier 1–2, and non-stimulants (atomoxetine, guanfacine ER) at Tier 1–2. Brand-name stimulants and newer agents like Qelbree are typically placed at Tier 3–4 and may require prior authorization.

Does Aetna require prior authorization for Adderall or Vyvanse?

Generic amphetamine salts (Adderall generic) and generic lisdexamfetamine (Vyvanse generic) are often covered at Tier 1–2 without PA for most Aetna commercial plans. Brand Vyvanse may require prior authorization where a generic equivalent is available. PA requirements vary by specific plan — confirm through the CVS/Caremark portal or your provider’s billing team.

Can I see a telehealth provider for ADHD under my Aetna plan?

Many Aetna plans in Mississippi cover telehealth behavioral health visits. Whether your specific telehealth provider is in-network and whether telehealth ADHD visits are covered at parity depends on your plan type. PPO members generally have more flexibility to use out-of-network telehealth providers, while HMO and EPO members should confirm in-network status before scheduling.

Does Mississippi’s mental health parity law apply to my Aetna plan?

If your Aetna plan is a fully insured commercial plan sold in Mississippi, Miss. Code Ann. § 83-9-353 et seq. typically applies. Employer-sponsored plans that are self-funded under ERISA are generally exempt from state parity law but remain subject to federal MHPAEA requirements.

Do stimulant ADHD prescriptions require EPCS in Mississippi?

Yes. Stimulant ADHD medications are Schedule II controlled substances under federal law. Mississippi requires EPCS for Schedule II prescriptions under Miss. Code Ann. § 456.44. Your provider must use a DEA-registered, EPCS-compliant system. Non-stimulant medications (atomoxetine, guanfacine, viloxazine, bupropion) are not Schedule II and do not require EPCS.

What if my Aetna claim for ADHD treatment is denied?

You have the right to appeal a denied claim or PA. Aetna must provide a written explanation of the denial and information on how to appeal. Under MHPAEA, mental health denials must be evaluated under the same criteria as comparable medical/surgical benefit denials. Contact Aetna member services at 1-800-872-3862 to begin an appeal, or contact the MS DOI at 1-800-562-2957 if you believe parity rules are being violated.

Does Aetna cover ADHD treatment in Mississippi for adults?

Most Aetna commercial plans cover ADHD treatment for adults as a covered behavioral health benefit, subject to the same plan terms (deductibles, copays, PA requirements) that apply to other outpatient mental health services. Adult ADHD is a recognized clinical diagnosis covered under standard MHPAEA-compliant plans. Confirm your specific adult behavioral health coverage with Aetna at 1-800-872-3862.

Disclaimer: Coverage details vary by individual Aetna plan, employer group, and formulary year. This guide is for informational purposes only and does not constitute insurance, legal, or medical advice. Always verify your specific benefits with Aetna before scheduling care or filling a prescription. Klarity Health is not affiliated with Aetna, CVS Health, or CVS/Caremark. Check if ADHD treatment may be right for you →